| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,497 |
8,797 |
$804K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,557 |
3,190 |
$442K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,213 |
3,604 |
$327K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
470 |
424 |
$27K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,560 |
1,469 |
$22K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
578 |
478 |
$17K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
460 |
392 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,042 |
496 |
$15K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
231 |
193 |
$12K |
| 87428 |
|
173 |
156 |
$9K |
| 99000 |
|
591 |
552 |
$2K |
| 81025 |
|
152 |
147 |
$1K |
| 81003 |
|
435 |
417 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
13 |
$51.33 |